Intermediate hepatocellular carcinoma: The role of transarterial therapy Journal Article
| Authors: | Chegai, F.; Orlacchio, A.; Merolla, S.; Monti, S.; Mannelli, L. |
| Article Title: | Intermediate hepatocellular carcinoma: The role of transarterial therapy |
| Abstract: | According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, transarterial therapies have proved precious in the treatment of hepatic malignancies. During the last years, there were important developments in practiced transarterial therapies and their efficacy is still controversial. The purpose of this review is to discuss in further details these transarterial therapies that have been used to treat cases of HCC. © 2015 Future Medicine Ltd. |
| Keywords: | survival rate; overall survival; mortality; review; cancer recurrence; hepatocellular carcinoma; cisplatin; doxorubicin; iodinated poppyseed oil; artificial embolism; chemoembolization; liver cell carcinoma; liver cirrhosis; liver function; monotherapy; patient selection; disease free survival; chemotherapy; cancer staging; gold standard; progression free survival; tumor volume; vascularization; risk factor; health care quality; alkaline phosphatase; survival time; whole body radiation; conservative treatment; hepatomegaly; liver tumor; operation duration; epirubicin; maximum plasma concentration; external beam radiotherapy; bone marrow transplantation; tumor vascularization; radioactive microsphere; systemic circulation; particle size; alpha fetoprotein; patient; embolization; liver blood flow; artery occlusion; yttrium 90; artery blood flow; radioembolization; long term survival; child pugh score; operative blood loss; human; priority journal; gangrene; transarterial therapy; deb tace; interventional treatment; transarterial chemo-occlusion; cyanoacrylate; starch microsphere |
| Journal Title: | Hepatic Oncology |
| Volume: | 2 |
| Issue: | 4 |
| ISSN: | 2045-0923 |
| Publisher: | Future Medicine |
| Date Published: | 2015-10-01 |
| Start Page: | 399 |
| End Page: | 408 |
| Language: | English |
| DOI: | 10.2217/hep.15.32 |
| PROVIDER: | scopus |
| PMCID: | PMC4792112 |
| PUBMED: | 26998220 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 3 October 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work